The global point of care molecular diagnostics market was valued at $ 1.91 Bn in 2019 and the market will expand at a moderate CAGR of 13% from 2020 to 2030.
insightSLICE recently added a research report, Point of Care Molecular Diagnostics Market - global industry size, market share, trends, analysis, and forecast, 2020 – 2030, that identifies numerous growth opportunities that shaping the scale of these market.
The Point of Care Molecular Diagnostics Market research report offers market estimates for a period 2018 to 2030, wherein 2018 is historic period, 2019 is the base year, and 2020 to 2030 is forecast period.
The wide application portfolio of Point of Care Molecular Diagnostics Market is one of factors driving the growth of market worldwide. The global market is moderately competitive with a blend of global and regional players. The market players invest significantly in R&D to enhance their offerings. The entire ecosystem is composed of multiple participants. Every participant of the ecosystem is an equal contributor to the growth of global market.
The report provides an understanding of the market composition and explains the role of established players and the regional contributors. The global demand is witnessing a temporary dip in demand owing to sudden pandemic of COVID-19. However, the analysts predict a resurgence of demand in the second half of 2021. It is essential for the market players to make calculative moves in uncertain times and focus on client retention by entering long term associations. In order to maintain their share, the market players are focusing on product differentiation. The next five year duration is expected to bring in healthy growth to the market at a global level.
We Provide You Updated Sample Report, Download FREE SAMPLE PDF (Including Full TOC, Table & Figures) @ https://www.insightslice.com/request-sample/501
The leading revenue generating segments have been thoroughly explained in the report along with the supporting facts. The report includes graphical and textual representation for capturing the change in market size through every year. Along with the year over year growth, aggregate growth has been calculated and represented for 2020 – 2030. Investment by the market players for enhanced production along with strategic collaborations between ecosystem participants is anticipated to ensure growth throughout the forecast period.
Geographically, the market has been analyzed across five regions that constitute the globe. The macro and micro economic factors including application sectors, government regulations, raw material price fluctuations, socioeconomic factors and so on have been studied across all five regions. The major demand generating countries have been explicitly valued in terms of revenue.
The market competition has been analyzed and the shares held by prominent companies have been estimated. The profiles of global leading companies are described in the report. The inclusions of company profile are the overview, offerings portfolio, financial performance, strategy adopted and relevant recent collaborations. All this put together, would help the reader of report in making important business decisions.
Major players active in the global Point of Care Molecular Diagnostics Market include Johnson and Johnson, Abbott Laboratories, F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Danaher Corporation, BioMerieux, Cepheid, Inc., Bio-Rad Laboratories, Inc.,and Bayer Healthcare.
Market Segmentation as below:
For better understanding of the global Point of Care Molecular Diagnostics Market, analysts have segmented the market.
The global market is segregated on the basis of application, technology, test location, end-use, and geography.
The application segment is classified into Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications.
Based on technology the market is segmented into PCR-based, Genetic Sequencing-based, Hybridization-based, and Microarray-based. Depending on the test location the POC molecular diagnostic market is divided into Over the Counter and PoC.
Based on end-use segment the market is classified into Decentralized Labs, Hospitals, Homecare, Assisted Living Healthcare Facilities, and Other Uses.
(Regional Output, Demand & Forecast by Countries)
- North America
- Asia Pacific
- Middle East & Africa
- South America
Customized Requirements? Inquiry Before Buying? Please Email us at firstname.lastname@example.org
The Final Report will cover the impact analysis of COVID-19.
Key Questions Answered by the Report:
- What will be the size of the global Point of Care Molecular Diagnostics Market in 2030?
- What is the expected CAGR for the global market from 2020 - 2030?
- Which are the top players active in the global market?
- What are the key drivers of the global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in the market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global Point of Care Molecular Diagnostics Market?
The final report will cover the impact analysis of COVID-19.
Download Full Study Report (Single User License US$ 3200) @ https://www.insightslice.com/buy-now/501
We are a team of research analysts and management consultants with a common vision to assist individuals and organizations in achieving their short and long term strategic goals by extending quality research services. The inception of insightSLICE was done to support established companies, start-ups as well as non-profit organizations across various industries including Packaging, Automotive, Healthcare, Chemicals & Materials, Industrial Automation, Consumer Goods, Electronics & Semiconductor, IT & Telecom and Energy among others. Our in-house team of seasoned analysts hold considerable experience in the research industry.
Phone: +1 (707) 736-6633